Fingerprint
Dive into the research topics of 'MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically